Topic: research

Papua New Guineans are living proof of how isolation, ancient mixing, and survival in remote islands can preserve a unique piece of our shared human story.

A research study by the Institute of Genomics at the University of Tartu reveals that genetic variants influencing drug metabolism and disease susceptibility affect medication dosing.

Researchers at the University of Tartu’s Institute of Genomics have gained deeper understanding of why some people are more prone to experiencing side effects when taking antidepressants.

On 23 May 2025, Minister of Education and Research Kristina Kallas approved the results of the external evaluation of Estonian research and development. The University of Tartu was the only institution in Estonia to receive a positive evaluation in all six fields: natural sciences, engineering and technology, medical and health sciences, agriculture and veterinary sciences, social sciences, and humanities and the arts.

Õhusaaste, tihedalt arendatud linnakeskkonna ja piiratud rohealade kombinatsioon suurendab astma riski nii lastel kui täiskasvanutel. Sellisele järeldusele jõuti värskes uuringus, mis koostati suure Euroopa Liidu teaduskoostöö raames Karolinska Instituudi teadlaste juhtimisel koostöös Tartu Ülikooli genoomika instituudiga.

Our research leverages diverse omics and electronic health record data modalities to study human disease predisposition, development, and progression trajectories.

Doctoral studies are a part of the career path, giving you the knowledge and future skills needed to become a top specialist or manager.

We are looking for a postdoctoral researcher in population and/or statistical genetics to develop polygenic risk scores.

A recently published study in Genome Biology and Evolution provides new insights into the settlement of Pacific islands and the migrations of Austronesian-speaking peoples, helping to understand human movement and cultural interactions in the region.

An international expert group has published the first evidence-based clinical guidance on the use of polygenic risk scores (PRSs) for breast cancer. Published in the peer-reviewed journal Cancers, the guidance provides concrete recommendations on where to integrate PRS testing into routine healthcare for personalised breast cancer prevention and screening.